Apomorphine and levodopa in Parkinson's disease: Two revolutionary drugs from the 1950's
- PMID: 28012951
- DOI: 10.1016/j.parkreldis.2016.12.004
Apomorphine and levodopa in Parkinson's disease: Two revolutionary drugs from the 1950's
Abstract
This article reviews the history of apomorphine and levodopa, which were both discovered in the 1950's and have revolutionized treatment paradigms of Parkinson's disease. Although the discovery of levodopa is a prime example of successful translation of basic neuroscience into clinical routine, the history of apomorphine was based on less solid evidence. Despite this, both drugs are, more than 6 decades after the first clinical experiments, still the two most efficacious medications to treat patients with Parkinson's disease. New and promising delivery strategies for both levodopa and apomorphine are currently under investigation to further improve clinical responses.
Keywords: Apomorphine; History; Levodopa.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Levodopa: 50 years of a revolutionary drug for Parkinson disease.Mov Disord. 2015 Jan;30(1):1-3. doi: 10.1002/mds.26122. Epub 2014 Dec 8. Mov Disord. 2015. PMID: 25488146 No abstract available.
-
Hallmarks of Treatment Aspects: Parkinson's Disease Throughout Centuries Including l-Dopa.Int Rev Neurobiol. 2017;132:295-343. doi: 10.1016/bs.irn.2017.01.006. Epub 2017 Mar 20. Int Rev Neurobiol. 2017. PMID: 28554412 Review.
-
Parkinson's disease. A half century of progress.Neurology. 2001 Nov;57(10 Suppl 3):S1-3. Neurology. 2001. PMID: 11771154 No abstract available.
-
How L-DOPA was discovered as a drug for Parkinson's disease 40 years ago.Wien Klin Wochenschr. 2001 Nov 15;113(22):855-62. Wien Klin Wochenschr. 2001. PMID: 11762121 No abstract available.
-
The history of dopamine and levodopa in the treatment of Parkinson's disease.Mov Disord. 2008;23 Suppl 3:S497-508. doi: 10.1002/mds.22028. Mov Disord. 2008. PMID: 18781671 Review.
Cited by
-
5-Amino-3-methyl-Isoxazole-4-carboxylic Acid as a Novel Unnatural Amino Acid in the Solid Phase Synthesis of α/β-Mixed Peptides.Molecules. 2022 Aug 31;27(17):5612. doi: 10.3390/molecules27175612. Molecules. 2022. PMID: 36080386 Free PMC article.
-
Parkinson's disease, dopaminergic drugs and the plant world.Front Pharmacol. 2022 Sep 5;13:970714. doi: 10.3389/fphar.2022.970714. eCollection 2022. Front Pharmacol. 2022. PMID: 36133818 Free PMC article. Review.
-
Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson's disease.J Neural Transm (Vienna). 2023 Nov;130(11):1337-1347. doi: 10.1007/s00702-023-02655-0. Epub 2023 May 20. J Neural Transm (Vienna). 2023. PMID: 37210460 Free PMC article. Review.
-
Computational analysis of RNA methyltransferase Rv3366 as a potential drug target for combating drug-resistant Mycobacterium tuberculosis.Front Mol Biosci. 2024 Jan 11;10:1348337. doi: 10.3389/fmolb.2023.1348337. eCollection 2023. Front Mol Biosci. 2024. PMID: 38274093 Free PMC article.
-
Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience.Sci Rep. 2023 Oct 31;13(1):18681. doi: 10.1038/s41598-023-46003-4. Sci Rep. 2023. PMID: 37907679 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical